Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome
Restricted accessResearch articleFirst published online April, 2017
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome
Systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APS) are autoimmune diseases that affect women of childbearing age. Maternal IgG antiphospholipid antibodies (aPL) can cross the placenta during pregnancy and theoretically reach the fetal brain. Some studies showed an increased number of learning disabilities in these children.
Objectives
To evaluate the long-term neurodevelopmental outcome of 40 children (median age 7.4 years) born to mothers with SLE and/or APS carrying positive IgG aPL during the third trimester of pregnancy.
Methods
Children were checked for neurological physical exam and intellectual/cognitive functioning by the Wechsler scale for corrected age. We submitted to the mothers the Child Behavior CheckList (CBCL) and a homemade set of questions created by pediatric neurologists.
Results
In all children neurological physical exam and intelligence levels were found to be normal. A cognitive impairment or a discrepant cognitive profile was found in 3 (7%) and 11 (28%) children, respectively. Learning disabilities were diagnosed in 3 children (19% of school-age children), all born to mothers with triple aPL positivity. A history of epilepsy was shown in four children (10%). Conclusions: Children born to women with SLE and/or APS may need a long-term follow-up focusing on milestones of neurodevelopment in order to detect and correct any alteration as early as possible.
NalliCIodiceAAndreoliL. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes. Lupus2014; 23(6): 507–517.
2.
VinetÉPineauCAClarkeAEFombonneÉPlattRWBernatskyS. Neurodevelopmental disorders in children born to mothers with systemic lupus erythematosus. Lupus2014; 23(11): 1099–1104.
3.
LahitaRG. Systemic lupus erythematosus: Learning disabilities in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology1988; 13: 385–396.
4.
RossGSammaritanoLNassRLockshinM. Effects of mothers’ autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med2003; 157: 397–402.
5.
NeriFChiminiLBonomiF. Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus2004; 13: 805–811.
6.
KatzavAPickCGKorczynAD. Hyperactivity in a mouse model of the antiphospholipid syndrome. Lupus2001; 10(7): 496–499.
7.
MottaMChiricoGRebaioliCB. Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: A follow-up study. Am J Perinatol2006; 23(4): 247–251.
8.
MekinianALachassinneENicaise-RolandP. European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis2013; 72: 217–222.
9.
UrowitzMBGladmanDDMacKinnonA. Neurocognitive abnormalities in offspring of mothers with systemic lupus erythematosus. Lupus2008; 17: 555–560.
10.
NacinovichRGalliJBombaM. Neuropsychological development of children born to patients with antiphospholipid syndrome. Arthritis Rheum2008; 59: 345–351.
11.
MarderWGanserMARomeroV. In utero azathioprine exposure and increased utilization of special educational services in children born to mothers with systemic lupus erythematosus. Arthritis Care Res (Hoboken)2013; 65(5): 759–766.
12.
BrucatoAAstoriMGCimazR. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero. Ann Rheum Dis2006; 65(11): 1422–1426.
13.
DevreeseKMPierangeliSSde LaatBTripodiAAtsumiTOrtelTL. Testing for antiphospholipid antibodies with solid phase assays: Guidance from the SSC of the ISTH. J Thromb Haemost2014; 12(5): 792–795.
14.
TincaniAAllegriFBalestrieriG. Minimal requirements for antiphospholipid antibodies ELISAs proposed by the European Forum on antiphospholipid antibodies. Thromb Res2004; 114(5–6): 553–558.
15.
BalestrieriGTincaniASpatolaL. Anti-beta 2-glycoprotein I antibodies: A marker of antiphospholipid syndrome?Lupus1995; 4(2): 122–130.
16.
A Orsini, L Picone (eds). WISC-III Wechsler Intelligence Scale for Children–III. Firenze: Giunti OS, 2006.
17.
CornoldiC. Prove di Lettura MT-2 per la Scuola Primaria, Firenze: Organizzazioni Speciali, 2011.
18.
CornoldiC. Test AC-MT 6-11 di valutazione delle abilità di calcolo, Trento (Italy): Erickson, 2002.
19.
“Disturbi specifici dell’apprendimento”. Documento di intesa, PARCC, 1 febbraio, 2011. Available at: www.lineeguidadsa.it.
LojaconoASpatolaLFadenDTincaniABalestrieriG. Fetal stroke associated with maternal antiphospholipid antibodies: A case report. Lupus1996; 5(5): 512–512.
22.
MortzCGLauritsenJMBindslev-JensenCAndersenKE. Prevalence of atopic dermatitis, asthma, allergic rhinitis, and hand and contact dermatitis in adolescents. The Odense Adolescence Cohort Study on Atopic Diseases and Dermatitis. Br J Dermatol2001; 144(3): 523–532.
23.
ParisiRSymmonsDPGriffithsCEAshcroftDM. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol2013; 133(2): 377–385.
24.
NgugiAKKariukiSMBottomleyCKleinschmidtISanderJWNewtonCR. Incidence of epilepsy: A systematic review and meta-analysis. Neurology2011; 77(10): 1005–1012.
25.
Abu-ArafehIRazakSSivaramanBGrahamC. Prevalence of headache and migraine in children and adolescents: A systematic review of population-based studies. Dev Med Child Neurol2010; 52(12): 1088–1097.
26.
MeltzerLJJohnsonCCrosetteJRamosMMindellJA. Prevalence of diagnosed sleep disorders in pediatric primary care practices. Pediatrics2010; 125(6): e14108–e14108.
27.
Brimberg L, Mader S, Jeganathan V, et al. Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice. Mol Psychiatry 2016; 21: 1663–1671.
28.
BrimbergLSadiqAGregersenPKDiamondB. Brain-reactive IgG correlates with autoimmunity in mothers of a child with an autism spectrum disorder. Mol Psychiatry2013; 18(11): 1171–1177.
29.
BrimbergLMaderSFujiedaY. Antibodies as mediators of brain pathology. Trends Immunol2015; 36(11): 709–724.
30.
PirasISHaapanenLNapolioniVSaccoRVan de WaterJPersicoAM. Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with autism spectrum disorder. Brain Behav Immun2014; 38: 91–99.
31.
KatzavABen-ZivTBlankMPickCGShoenfeldYChapmanJ. Antibody-specific behavioral effects: Intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. J Neuroimmunol2014; 272(1–2): 10–15.
32.
KatzavAMenachemAMaggioN. IgG accumulates in inhibitory hippocampal neurons of experimental antiphospholipid syndrome. J Autoimmun2014; 55: 86–93.
33.
FrauenknechtKKatzavAWeiss LaviR. Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones. Neuropathol Appl Neurobiol2015; 41(5): 657–671.
34.
LeeJYHuertaPTZhangJ. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med2009; 15(1): 91–96.
35.
ChangEHVolpeBTMackayM. Selective impairment of spatial cognition caused by autoantibodies to the N-Methyl-D-aspartate receptor. EBioMedicine2015; 2(7): 755–764.
36.
MarderWRomeroVCGanserMA. Increased usage of special educational services by children born to mothers with systemic lupus erythematosus and antiphospholipid antibodies. Lupus Sci Med2014; 1(1): e000034–e000034.
37.
MockováAUlčová-GallováZNáhlovskýJ. Occurrence of selected antiphospholipid antibodies in offspring born from mothers with autoimmunity. Lupus2012; 21(7): 793–795.
38.
YoshikawaNTanakaKSekigawaM. Neurodevelopment in the offspring of Japanese systemic lupus erythematosus patients. Brain Dev2010; 32(5): 390–395.
39.
VinetÉPineauCAClarkeAE. Increased risk of autism spectrum disorders in children born to women with systemic lupus erythematosus: Results from a large population-based cohort. Arthritis Rheumatol2015; 67(12): 3201–3208.
40.
SannaGBertolacciniMLHughesGR. Hughes syndrome, the antiphospholipid syndrome: A new chapter in neurology. Review. Ann N Y Acad Sci2005; 1051: 465–486.
41.
Cimaz R, Romeo A, ScaranoA. Prevalence of anti-cardiolipin, anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy. Epilepsia2002; 43(1): 52–59.
BombaMGalliJNacinovichR. Neuropsychiatric aid in children born to patients with rheumatic diseases. Clin exp Rheumatol2010; 28(5): 767–773.
44.
BarkmannCRomerGWatsonMSchulte-MarkwortM. Parental physical illness as a risk for psychosocial maladjustment in children and adolescents: Epidemiological findings from a national survey in Germany. Psychosomatics2007; 48(6): 476–481.
45.
BarbieroCLonciariIMonticoM. The submerged dyslexia iceberg: How many school children are not diagnosed? Results from an Italian study. PLoS One2012; 7(10): e48082–e48082.
46.
BertolacciniMLContentoGLennenR. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome. J Autoimmun2016; 75: 30–38.
